LWA
IMCR icon

Lowe Wealth Advisors’s Immunocore IMCR Stock Holding History

Lowe Wealth Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12K Hold
330
– – ﹤0.01% 245
2025
Q2 		$10.4K Hold
330
– – ﹤0.01% 250
2025
Q1 		$9.79K Buy
+330
New +$9.9K ﹤0.01% 249

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Lowe Wealth Advisors's IMCR Position: Q3 2025 in Review

Lowe Wealth Advisors held its Immunocore (IMCR) position steady in Q3 2025 at 330 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

Lowe Wealth Advisors first reported a position in IMCR in Q1 2025 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • Lowe Wealth Advisors held 330 shares of Immunocore worth $12K as of Q3 2025.
  • Lowe Wealth Advisors left its Immunocore share count unchanged in Q3 2025.
  • Immunocore made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #245 holding.
  • Lowe Wealth Advisors first reported a position in Immunocore in Q1 2025 and has held it in 3 quarters since.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.